Development and Steps for Implementation of the ASCVD Pooled Cohort Risk Equations S71 Characteristics of Previously Published Risk Scores and Current Pooled Cohort Equations S70Īppendix 7. Evidence Statements for CQ2 S69Īppendix 6. Evidence Statements for CQ1 S66Īppendix 5. Expert Reviewer Relationships With Industry and Other Entities S65Īppendix 4. Author Relationships With Industry and Other Entities (Relevant) S62Īppendix 2. Evidence Gaps and Future Research Needs S59Īppendix 1. Implementation Considerations for Risk Assessment S59Ĩ. Recommendations for CQ2: Long-Term Risk Assessment S59ħ. Recommendations for CQ1: Use of Newer Risk Markers After Quantitative Risk Assessment S58Ħ.2.2. Summary of Systematic Reviews and Meta-Analyses for CQ1 S56Ħ.1.2. CQs and Systematic Evidence Review S56Ħ.1.1. Recommendations for Assessment of 10-Year Risk of a First Hard ASCVD Event S55Ħ. Development of New Pooled Cohort ASCVD Risk Equations S55Ĥ.1. Preamble and Transition to ACC/AHA Guidelines to Reduce Cardiovascular Risk S50Ĥ. Customer Service and Ordering Information.Stroke: Vascular and Interventional Neurology.Journal of the American Heart Association (JAHA).Circ: Cardiovascular Quality & Outcomes.Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |